Bentham Science Logo

Track Your Manuscript:


Letters in Drug Design & Discovery

Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Letters in Drug Design & Discovery, Volume 4 - Number 5


Stereochemistry as a Determinant of the Anti-Leukemic Potency of Halopyridyl and Thiazolyl Thiourea Compounds

, 4(5): 318 - 326

Taracad K. Venkatachalam, Alexi O. Vassilev, Alexi Benyunov, Olga O. Grigoriants, Heather E. Tibbles and Fatih M. Uckun


DOI: 10.2174/157018007780867870



The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug

, 4(5): 336 - 340

Rudolf Lucas, Harald Hundsberger, Maren Pfluger, Bernhard Fischer, Denis Morel, Clemens Braun, Albrecht Wendel, Trinad Chakraborty, Wolfgang Schutt, Christoph Wiesner and Jurg Hamacher


DOI: 10.2174/157018007780867816


Synthesis and Cytotoxic Activity of Cisplatin Analogue with an Ursodeoxycholate Ligand

, 4(5): 341 - 345

Martin Perez-Andres, Juan Jose Benito, Emilio Rodriguez-Fernandez, Juan Luis Manzano, Susana Barrena, Alberto Orfao and Julio Jose Criado


DOI: 10.2174/157018007780867898









Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)

Biography
View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05

Advertisement

PLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog